Giordano de Guglielmo Selected Research

paraform (paraformaldehyde)

5/2021

The Cocaine and Oxycodone Biobanks, Two Repositories from Genetically Diverse and Behaviorally Characterized Rats for the Study of Addiction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giordano de Guglielmo Research Topics

Disease

12	Alcoholism (Alcohol Abuse) 03/2024 - 11/2009
9	Opioid-Related Disorders (Opiate Addiction) 10/2023 - 12/2014
8	Cocaine-Related Disorders (Cocaine Addiction) 11/2023 - 03/2013
6	Hyperalgesia 10/2023 - 05/2018
6	Substance-Related Disorders (Drug Abuse) 01/2023 - 12/2014
3	Inflammation (Inflammations) 01/2022 - 01/2019
3	Body Weight (Weight, Body) 01/2020 - 01/2017
2	Heroin Dependence (Heroin Abuse) 01/2018 - 08/2017
2	Anxiety Disorders (Anxiety Disorder) 07/2013 - 03/2012
2	Partial Epilepsies (Epilepsy, Partial) 07/2013 - 03/2012
2	Neuralgia (Stump Neuralgia) 07/2013 - 03/2012
1	Respiratory Insufficiency (Respiratory Failure) 10/2023
1	Amphetamine-Related Disorders (Addiction, Amphetamine) 05/2023
1	Morphine Dependence 05/2023
1	Cognitive Dysfunction 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Drug Overdose 01/2022
1	Prescription Drug Misuse 01/2022
1	Pain (Aches) 05/2020
1	Disease Progression 01/2020
1	Food Addiction 01/2020
1	Chronic Pain 01/2020
1	Tobacco Use Disorder (Nicotine Dependence) 11/2019
1	Hyperuricemia 01/2019
1	Gout 01/2019
1	Weight Gain 01/2018
1	Mental Disorders (Mental Disorder) 01/2017
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2017
1	Acute Pain 01/2017
1	Insulin Resistance 08/2013
1	Type 2 Diabetes Mellitus (MODY) 08/2013

Drug/Important Bio-Agent (IBA)

9	Opioid Analgesics (Opioids)IBA 01/2023 - 12/2014
5	Oxycodone (Oxycontin)FDA LinkGeneric 10/2023 - 01/2019
4	Analgesics (Analgesic Drugs)IBA 10/2023 - 12/2014
4	Nicotine FDA Link 10/2020 - 04/2015
4	NociceptinIBA 01/2017 - 11/2009
3	Ethanol (Ethyl Alcohol)IBA 01/2024 - 01/2017
3	Cocaine (Cocaine HCl)IBA 01/2022 - 01/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2024 - 08/2013
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 01/2021
2	LeptinIBA 01/2022 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2015
2	Pioglitazone (Actos)FDA Link 01/2017 - 08/2013
2	Peptides (Polypeptides)IBA 01/2017 - 07/2015
2	Aminobutyrates (Aminobutyric Acid)IBA 07/2013 - 03/2012
2	Pregabalin (Lyrica)FDA Link 07/2013 - 03/2012
2	gamma-Aminobutyric Acid (GABA)IBA 07/2013 - 03/2012
1	Tolcapone (Tasmar)FDA Link 01/2024
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2024
1	ChromatinIBA 11/2023
1	MicroRNAs (MicroRNA)IBA 05/2023
1	Nerve Growth Factors (Neurotrophins)IBA 05/2023
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2023
1	BenzodiazepinesIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	paraform (paraformaldehyde)IBA 05/2021
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2020
1	Uric Acid (Urate)IBA 01/2019
1	Benzoic Acid (Potassium Benzoate)FDA Link 01/2019
1	Probenecid (Benemid)FDA LinkGeneric 01/2019
1	Organic Anion TransportersIBA 01/2019
1	Dopamine D3 ReceptorsIBA 01/2019
1	VK4-116IBA 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2018
1	A-factor (Streptomyces)IBA 01/2018
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2018
1	CannabinoidsIBA 01/2018
1	Heroin (Diamorphine)IBA 08/2017
1	Therapeutic UsesIBA 08/2017
1	Corticotropin-Releasing HormoneIBA 01/2017
1	Calcium Channels (Calcium Channel)IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Naloxone (Narcan)FDA LinkGeneric 01/2017
1	Opioid Receptors (Opioid Receptor)IBA 01/2017
1	Morphine (MS Contin)FDA LinkGeneric 01/2017
1	6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2015
1	Naltrexone (ReVia)FDA LinkGeneric 08/2013
1	ElementsIBA 03/2013
1	Nociceptin ReceptorIBA 11/2009
1	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2009
1	NeuropeptidesIBA 11/2009

Therapy/Procedure

11	Self Administration (Administration, Self) 10/2023 - 07/2017
3	Therapeutics 01/2022 - 08/2017
1	Pain Management 01/2019
1	Deep Brain Stimulation 08/2017
1	Secondary Prevention 07/2015